Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis

被引：3

作者：

Nishibu, Akiko ^{[1
,2
]}

Sakai, Erika ^{[1
]}

Oyama, Noritaka ^{[1
]}

Yamamoto, Toshiyuki ^{[1
]}

机构：

[1] Fukushima Med Univ, Dept Dermatol, Fukushima, Japan

[2] Kanazawa Med Univ, Dept Dermatol, Kanazawa, Ishikawa, Japan

来源：

AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2012年 / 53卷 / 02期

关键词：

bosentan; endothelin; systemic sclerosis; DIGITAL ULCERS;

D O I：

10.1111/j.1440-0960.2010.00719.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

We report a case of systemic sclerosis with interstitial pneumonia and severe pulmonary hypertension treated with bosentan, an endothelin receptor antagonist. Within a short period of administration of the bosentan the skin sclerosis improved.

引用

页码：E32 / E33

页数：2

共 50 条

[1] Longterm Treatment with Endothelin Receptor Antagonist Bosentan and Iloprost Improves Fingertip Blood Perfusion in Systemic Sclerosis
Cutolo, Maurizio
Ruaro, Barbara
Pizzorni, Carmen
Ravera, Francesca
Smith, Vanessa
Zampogna, Giuseppe
Paolino, Sabrina
Seriolo, Bruno
Cimmino, Marco
Sulli, Alberto
JOURNAL OF RHEUMATOLOGY, 2014, 41 (05) : 881 - 886
[2] Digital ulcers in systemic sclerosis - Prevention by treatment with bosentan, an oral endothelin receptor antagonist
Korn, JH
Mayes, M
Cerinic, MM
Rainisio, M
Pope, J
Hachulla, E
Rich, E
Carpentier, P
Molitor, J
Seibold, JR
Hsu, V
Guillevin, L
Chatterjee, S
Peter, HH
Coppock, J
Herrick, A
Merkel, PA
Simms, R
Denton, CP
Furst, D
Nguyen, N
Gaitonde, M
Black, C
ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 3985 - 3993
[3] Improvement of vascular endothelial function using the oral endothelin receptor antagonist Bosentan in patients with systemic sclerosis
Sfikakis, P. P.
Papamichael, C.
Starnatelopoulos, K. S.
Tousoulis, D.
Fragiadaki, K. G.
Katsichti, P.
Stefanadis, C.
Mavrikakis, M.
ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1985 - 1993
[4] Successful treatment of systemic sclerosis digital ulcers and pulmonary arterial hypertension with endothelin receptor antagonist bosentan
Humbert, M
Cabane, J
RHEUMATOLOGY, 2003, 42 (01) : 191 - 193
[5] Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy
Tillon, J
Hervé, F
Chevallier, D
Muir, JF
Levesque, H
Marie, I
BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (05) : 1000 - 1002
[6] Treatment of digital ulcers in systemtic sclerosis with endothelin-1 receptor antagonist (bosentan)
Riccardi, M. T.
Chiala, A.
Iannone, F.
Grattagliano, V.
Covelli, M.
Lapadula, G.
REUMATISMO, 2007, 59 (02) : 135 - 139
[7] Bosentan, an Endothelin Receptor Antagonist, Improves Systemic Sclerosis-Related Peripheral Circulation Insufficiency Through Regulation of Oxidative Stress, Inflammation, and Nitric Oxide Bioavailability
Yagi, Shusuke
Akaike, Masashi
Iwase, Takashi
Aihara, Ken-ichi
Yoshida, Sumiko
Sumitomo-Ueda, Yuka
Kusunose, Kenya
Niki, Toshiyuki
Yamaguchi, Koji
Koshiba, Kunihiko
Taketani, Yoshio
Tomita, Noriko
Yamada, Hirotsugu
Soeki, Takeshi
Wakatsuki, Tetsuzo
Matsumoto, Toshio
Sata, Masataka
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E49 - E50
[8] Bosentan in systemic sclerosis
Heresi, Gustavo A.
Minai, Omar A.
DRUGS OF TODAY, 2008, 44 (06) : 415 - 428
[9] Bosentan: a dual endothelin receptor antagonist
Rubin, LJ
Roux, S
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (07) : 991 - 1002
[10] IMPROVEMENT OF DERMAL THICKNESS IN SYSTEMIC SCLEROSIS PATIENTS TREATED WITH ENDOTHELIN RECEPTOR ANTAGONIST: LONG TERM STUDY BY HIGH FREQUENCY ULTRASOUND
Ruaro, B.
Sulli, A.
Pizzorni, C.
Ghio, M.
Smith, V.
Tomatis, V.
Cutolo, M.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1507 - 1508

← 1 2 3 4 5 →